These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28402548)

  • 1. The Acylated/Unacylated Ghrelin Ratio Is Similar in Patients With Acromegaly During Different Treatment Regimens.
    Muhammad A; Delhanty PJD; Huisman M; Visser JA; Jan van der Lelij A; Neggers SJCMM
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2425-2432. PubMed ID: 28402548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
    Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
    Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acylated and unacylated ghrelin during OGTT in Prader-Willi syndrome: support for normal response to food intake.
    Kuppens RJ; Delhanty PJ; Huisman TM; van der Lely AJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):488-94. PubMed ID: 26850227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Changes in Acylated versus Unacylated Ghrelin Levels May Be Involved in the Underlying Mechanisms of the Switch in Nutritional Phases in Prader-Willi Syndrome.
    Grootjen LN; Diene G; Molinas C; Beauloye V; Huisman TM; Visser JA; Delhanty PJD; Kerkhof GF; Tauber M; Hokken-Koelega ACS
    Horm Res Paediatr; 2024; 97(4):343-352. PubMed ID: 37839403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?
    Muhammad A; van der Lely AJ; O'Connor RD; Delhanty PJ; Dal J; Dallenga AH; Feelders RA; Janssen JA; Jorgensen JO; Neggers SJ
    Eur J Endocrinol; 2016 May; 174(5):663-7. PubMed ID: 26903550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome.
    Beauloye V; Diene G; Kuppens R; Zech F; Winandy C; Molinas C; Faye S; Kieffer I; Beckers D; Nergårdh R; Hauffa B; Derycke C; Delhanty P; Hokken-Koelega A; Tauber M
    Orphanet J Rare Dis; 2016 May; 11(1):56. PubMed ID: 27146407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma acylated and plasma unacylated ghrelin: useful new biomarkers in patients with neuroendocrine tumors?
    van Adrichem RC; van der Lely AJ; Huisman M; Kramer P; Feelders RA; Delhanty PJ; de Herder WW
    Endocr Connect; 2016 Jul; 5(4):143-51. PubMed ID: 27215920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analogues.
    Franck SE; Korevaar TIM; Petrossians P; Daly AF; Chanson P; Jaffrain-Réa ML; Brue T; Stalla GK; Carvalho D; Colao A; Hána V; Delemer B; Fajardo C; van der Lely AJ; Beckers A; Neggers SJCMM
    Eur J Endocrinol; 2017 Apr; 176(4):421-431. PubMed ID: 28100630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acylated (AG) to unacylated (UAG) ghrelin ratio in esterase inhibitor-treated blood is higher than previously described.
    Delhanty PJ; Huisman M; Julien M; Mouchain K; Brune P; Themmen AP; Abribat T; van der Lely AJ
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):142-6. PubMed ID: 24810977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical performance of canine acylated and unacylated ghrelin enzyme-linked immunosorbent assays.
    Lass J; Nielsen ML; Bjørnvad CR; Vitger AD; Cremer SE
    Vet Clin Pathol; 2019 Dec; 48(4):748-753. PubMed ID: 31696557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
    Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of somatostatin analog-refractory growth hormone-secreting pituitary tumors with pegvisomant alone or combined with long-acting somatostatin analogs: a retrospective analysis of clinical practice and outcomes.
    Bianchi A; Valentini F; Iuorio R; Poggi M; Baldelli R; Passeri M; Giampietro A; Tartaglione L; Chiloiro S; Appetecchia M; Gargiulo P; Fabbri A; Toscano V; Pontecorvi A; De Marinis L
    J Exp Clin Cancer Res; 2013 Jun; 32(1):40. PubMed ID: 23799893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of total, acylated and unacylated ghrelin with apolipoprotein A1 and insulin concentrations in acromegalic patients.
    Komarowska H; Bromińska B; Sawicka-Gutaj N; Jaskula-Świtek M; Waśko R; Ruchała M; Bromiński G; Kotwicka M
    Adv Clin Exp Med; 2019 Jun; 28(6):789-795. PubMed ID: 30888121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of pegvisomant in combination with long-acting somatostatin analogs in acromegaly.
    Neggers SJ; Franck SE; de Rooij FW; Dallenga AH; Poublon RM; Feelders RA; Janssen JA; Buchfelder M; Hofland LJ; Jørgensen JO; van der Lely AJ
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3644-52. PubMed ID: 24937542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interictal ghrelin levels in adult patients with epilepsy.
    Varrasi C; Strigaro G; Sola M; Falletta L; Moia S; Prodam F; Cantello R
    Seizure; 2014 Nov; 23(10):852-5. PubMed ID: 25081601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of somatostatin analogues with pegvisomant in acromegaly.
    Franck SE; Muhammad A; van der Lely AJ; Neggers SJ
    Endocrine; 2016 May; 52(2):206-13. PubMed ID: 26661938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric bypass surgery may improve beta cell apoptosis with ghrelin overexpression in patients with BMI ≥ 32.5 kg/m(2.).
    Yang J; Feng X; Zhong S; Wang Y; Liu J
    Obes Surg; 2014 Apr; 24(4):561-71. PubMed ID: 24293163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegvisomant in combination with long-acting somatostatin analogues in acromegaly: the role of the GH receptor deletion of exon 3.
    Franck SE; van der Lely AJ; Delhanty PJ; Jørgensen JO; Neggers SJ
    Eur J Endocrinol; 2015 Nov; 173(5):553-61. PubMed ID: 26243033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome.
    Miller JL; Lacroix A; Bird LM; Shoemaker AH; Haqq A; Deal CL; Clark KA; Ames MH; Suico JG; de la Peña A; Fortier C
    J Clin Endocrinol Metab; 2022 May; 107(6):e2373-e2380. PubMed ID: 35213714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of medical therapies for acromegaly on glucose metabolism.
    Urbani C; Sardella C; Calevro A; Rossi G; Scattina I; Lombardi M; Lupi I; Manetti L; Martino E; Bogazzi F
    Eur J Endocrinol; 2013 Jul; 169(1):99-108. PubMed ID: 23660641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.